07.09.2010 • NewsUmicorenobel prize

Umicore Obtains License From Japan Science and Technology Agency

Umicore has signed a license agreement with Japan Science and Technology Agency expanding its technology offering to the nobel-prize winning asymmetric ketone hydrogenation technologies of professors Noyori and Ikariya. Under the license, Umicore is allowed to market Ruthenium diammine and diphosphine Ruthenium diammine catalysts on an industrial scale.

"With this technology expansion we are able to give our customers access to JST's extremely powerful technology," says Dr. Matthias Grehl, vice president BU precious metals chemistry. "Our customers can use these catalysts in their vessels to transfer ketones into chiral alcohols. This license complements our current intellectual property for chiral ligands and catalysts for example those of the MeOBIPHEP or Josiphos type."

The agreement underlines the strategic focus of Umicore precious metals chemistry on emerging applications for organometallic precious metals  chemistry in general and in homogeneous catalyst technologies in particular. Besides chiral catalysts, Umicore precious metals chemistry develops  catalysts for metathesis applications and for C-X coupling reactions, and provides innovative solutions for precious metals separation and recovery for homogeneous catalysis processes.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read